Table 3.
ROC curve analysis of the diagnostic ability of MIF, ITGA2, and COL2A1 in the validation phase.
Protein | AUC | 95% CI | Sensitivity | Specificity | P-value |
---|---|---|---|---|---|
MIF | 0.701 | 0.574–0.828 | 81.3% | 53.1% | 0.006 |
ITGA2 | 0.801 | 0.691–0.911 | 84.4% | 71.9% | <0.001 |
COL2A1 | 0.773 | 0.660–0.887 | 81.3% | 62.5% | <0.001 |
MIF and ITGA2 panel | 0.829 | 0.728–0.930 | 87.5% | 75.0% | <0.001 |
ITGA2 and COL2A1 panel | 0.867 | 0.777–0.958 | 81.3% | 87.5% | <0.001 |
MIF and COL2A1 panel | 0.822 | 0.720–0.924 | 84.4% | 71.9% | <0.001 |
Three-protein panel | 0.880 | 0.727–0.962 | 84.4% | 81.2% | <0.001 |